Factors associated with health-related quality of life in pediatric cancer survivors

被引:155
作者
Meeske, Kathleen A. [1 ]
Patel, Sunita K. [1 ]
Palmer, Stephanie N. [1 ]
Nelson, Mary B. [1 ]
Parow, Aimee M. [1 ]
机构
[1] Childrens Hosp Los Angeles, Childrens Ctr Canc & Blood Dis, HOPE Program, Los Angeles, CA 90027 USA
关键词
childhood cancer survivors; ethnicity; fatigue; late effects; quality of;
D O I
10.1002/pbc.20923
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Childhood cancer survivors are at risk for late effects of disease and treatment that may be attributed to multiple causes. This study describes health-related quality of life (HRQOL) in childhood cancer survivors and identifies factors related to poor quality of life outcomes. Procedure. Patients age 8-18 years, who attended the long-term information, follow-up, and evaluation (LIFE) clinic at Childrens Hospital Los Angeles during a 1-year time-period were eligible for the study. Eighty-six survivors (mean time off-treatment = 7.8 years) completed the Pediatric Quality of Life Inventory 4.0 Generic Core Scales, a LIFE Clinic Intake Questionnaire and rated their fatigue using a 10-point scale. Oncology nurses independently rated subjects' late effects using a 3-point severity scale. Linear regression procedures were used to evaluate the association between demographic and medical factors and HRQOL. Results. Fatigue and more severe late effects were associated with poorer physical functioning (fatigue, P < 0.02; late effects, P < 0.01). Fatigue, ethnic minority status, and a brain tumor diagnosis were associated with poorer psychosocial functioning (fatigue, P < 0.0001; minority status, P < 0.04; brain tumor, P < 0.01). Fatigue was the only factor related to both poor physical and psychosocial HRQOL. Conclusions. Long-term follow-up clinics for childhood cancer survivors are in a unique position to monitor HRQOL over time. Factors associated with poorer HRQOL include fatigue, ethnic minority status, a brain tumor diagnosis, and more severe late effects. Future studies need to clarify relationships between ethnicity, socioeconomic status (SES), and HRQOL in cancer survivors.
引用
收藏
页码:298 / 305
页数:8
相关论文
共 42 条
[1]   The Minneapolis-Manchester quality of life instrument: Reliability and validity of the Youth Form [J].
Bhatia, S ;
Jenney, MEM ;
Wu, E ;
Bogue, BMK ;
Rockwood, TH ;
Feusner, JH ;
Friedman, DL ;
Robison, LL ;
Kane, RL .
JOURNAL OF PEDIATRICS, 2004, 145 (01) :39-46
[2]   Racial and ethnic differences in survival of children with acute lymphoblastic leukemia [J].
Bhatia, S ;
Sather, HN ;
Heerema, NA ;
Trigg, ME ;
Gaynon, PS ;
Robison, LL .
BLOOD, 2002, 100 (06) :1957-1964
[3]  
Breslow NE, 1980, STAT METHODS CANC RE, V1, DOI DOI 10.1097/00002030-199912240-00009
[4]   Psychosocial and behavioral functioning among pediatric brain tumor survivors [J].
Carpentieri, SC ;
Meyer, EA ;
Delaney, BL ;
Victoria, ML ;
Gannon, BK ;
Doyle, JM ;
Kieran, MW .
JOURNAL OF NEURO-ONCOLOGY, 2003, 63 (03) :279-287
[5]   Minority adult survivors of childhood cancer: A comparison of long-term outcomes, health care utilization, and health-related behaviors from the Childhood Cancer Survivor Study [J].
Castellino, SM ;
Casillas, J ;
Hudson, MM ;
Mertens, AC ;
Whitton, J ;
Brooks, SL ;
Zeltzer, LK ;
Ablin, A ;
Castleberry, R ;
Hobbie, W ;
Kaste, S ;
Robison, LL ;
Oeffinger, KC .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (27) :6499-6507
[6]   EMPOWERING MINORITY-STUDENTS - A FRAMEWORK FOR INTERVENTION [J].
CUMMINS, J .
HARVARD EDUCATIONAL REVIEW, 1986, 56 (01) :18-36
[7]   Quality of life in children surviving cancer: A personality and multi-informant perspective [J].
De Clercq, B ;
De Fruyt, F ;
Koot, HM ;
Benoit, Y .
JOURNAL OF PEDIATRIC PSYCHOLOGY, 2004, 29 (08) :579-590
[8]  
Dow Karen Hassey, 2003, Oncol Nurs Forum, V30, P455, DOI 10.1188/03.ONF.455-469
[9]   The value of the PedsQLTM in assessing quality of life in survivors of childhood cancer [J].
Eiser, C ;
Vance, YH ;
Horne, B ;
Glaser, A ;
Galvin, H .
CHILD CARE HEALTH AND DEVELOPMENT, 2003, 29 (02) :95-102
[10]  
Ferraccioli G, 1996, J RHEUMATOL, V23, P1539